Return On Equity of Allogene Therapeutics, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Allogene Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Allogene Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -58%, a 0.48% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Return On Equity for 2024 was -55%, a 2.5% increase from 2023.
  • Allogene Therapeutics, Inc. annual Return On Equity for 2023 was -57%, a 28% decline from 2022.
  • Allogene Therapeutics, Inc. annual Return On Equity for 2022 was -44%, a 142% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Allogene Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -58% 0% +0.48% 01 Jul 2025 30 Sep 2025
Q2 2025 -59% -5% -8.6% 01 Apr 2025 30 Jun 2025
Q1 2025 -57% -3% -5.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -55% +1% +2.5% 01 Oct 2024 31 Dec 2024
Q3 2024 -58% -3% -5.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -54% +1% +1.8% 01 Apr 2024 30 Jun 2024
Q1 2024 -54% -2% -4.3% 01 Jan 2024 31 Mar 2024
Q4 2023 -57% -13% -28% 01 Oct 2023 31 Dec 2023
Q3 2023 -55% -26% -89% 01 Jul 2023 30 Sep 2023
Q2 2023 -55% -28% -107% 01 Apr 2023 30 Jun 2023
Q1 2023 -52% -27% -114% 01 Jan 2023 31 Mar 2023
Q4 2022 -44% -26% -142% 01 Oct 2022 31 Dec 2022
Q3 2022 -29% +2% +6.4% 01 Jul 2022 30 Sep 2022
Q2 2022 -27% +2% +7.9% 01 Apr 2022 30 Jun 2022
Q1 2022 -24% +3% +11% 01 Jan 2022 31 Mar 2022
Q4 2021 -18% +14% +44% 01 Oct 2021 31 Dec 2021
Q3 2021 -31% -3% -13% 01 Jul 2021 30 Sep 2021
Q2 2021 -29% +1% +4.2% 01 Apr 2021 30 Jun 2021
Q1 2021 -27% +6% +18% 01 Jan 2021 31 Mar 2021
Q4 2020 -32% -4% -14% 01 Oct 2020 31 Dec 2020
Q3 2020 -28% -4% -19% 01 Jul 2020 30 Sep 2020
Q2 2020 -30% +1% +4% 01 Apr 2020 30 Jun 2020
Q1 2020 -33% +55% +63% 01 Jan 2020 31 Mar 2020
Q4 2019 -29% +182% +86% 01 Oct 2019 31 Dec 2019
Q3 2019 -23% -264% -110% 01 Jul 2019 30 Sep 2019
Q2 2019 -31% 01 Apr 2019 30 Jun 2019
Q1 2019 -89% 01 Jan 2019 31 Mar 2019
Q4 2018 -210% 01 Oct 2018 31 Dec 2018
Q3 2018 241% 01 Jul 2018 30 Sep 2018

Allogene Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -55% +1% +2.5% 01 Jan 2024 31 Dec 2024
2023 -57% -13% -28% 01 Jan 2023 31 Dec 2023
2022 -44% -26% -142% 01 Jan 2022 31 Dec 2022
2021 -18% +14% +44% 01 Jan 2021 31 Dec 2021
2020 -32% -4% -14% 01 Jan 2020 31 Dec 2020
2019 -29% +182% +86% 01 Jan 2019 31 Dec 2019
2018 -210% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.